| Trial ID: | L0012 |
| Source ID: | NCT00941642
|
| Associated Drug: |
Lovaza
|
| Title: |
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Lovaza|Drug: placebo control
|
| Outcome Measures: |
To determine if Lovaza improves fibrosis and the NASH activity index.|To determine if Lovaza improves AST/ALT level and improves steatosis on biopsy.
|
| Sponsor/Collaborators: |
Huntington Medical Research Institutes|GlaxoSmithKline
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Treatment
|
| Start Date: |
September 2009
|
| Completion Date: |
September 2012
|
| Results First Posted: |
--
|
| Last Update Posted: |
June 10, 2010
|
| Locations: |
HMRI - Liver Center, Pasadena, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00941642
|
